Pediatric Endocrinology Diabetes and Metabolism
en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees

Journal integrated with

integrated with publons
Share:
Send email
Share:
Original paper

Neurofibromatosis type 1 from an endocrinologist’s perspective: a disease requiring coordinated care

Marta Teresa Burkietowicz
1
,
Agnieszka Zubkiewicz-Kucharska
1
,
Robert Stanisław Śmigiel
1

  1. Department of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases, Wrocław Medical University, Poland
Pediatr Endocrinol Diabetes Metab 2026; 32
DOI: https://doi.org/10.5114/pedm.2026.159281
Online publish date: 2026/02/23
Article file
- 0399_Neurofibromatosis type 1.pdf  [3.95 MB]
Get citation
 
PlumX metrics:
 
1. Easton DF, Ponder MA, Huson SM, Ponder BA. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993; 53: 305.
2. Miller DT, Freedenberg D, Schorry E, et al. Health supervision for children with neurofibromatosis type 1. Pediatrics 2019; 143: e20190660. doi: 10.1542/peds.2019-0660.
3. Legius E, Messiaen L, Wolkenstein P, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 2021; 23: 1506–1513. doi: 10.1038/s41436-021-01168-5.
4. Smyczyńska U, Smyczyński P. Kalkulator wzrostu (2016), wersja lokalna, nieopublikowana.
5. Tanner JM. Growth at Adolescence. 2nd ed. Blackwell Scientific Publications, Oxford 1962.
6. Maione L, Bouvattier C, Kaiser UB. Central precocious puberty: Recent advances in understanding the aetiology and in the clinical approach. Clin Endocrinol (Oxf) 2021; 95: 542–555. doi: 10.1111/cen.14475.
7. Narodowy Fundusz Zdrowia. Program lekowy: „Leczenie przedwczesnego dojrzewania płciowego u dzieci (ICD-10 E22.8) lub zagrażającej patologicznej niskorosłości na skutek szybko postępującego dojrzewania płciowego (ICD-10 E30.9)”. Available at: https://www.nfz.gov.pl/.
8. Charakterystyka Produktu Leczniczego. Diphereline SR 3,75 mg, proszek i rozpuszczalnik do sporządzania zawiesiny o przedłużonym uwalnianiu do wstrzykiwań.
9. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford University Press, Stanford 1959.
10. Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2 to 9 years allowing for height of parents. Arch Dis Child 1970; 45: 755–762. doi: 10.1136/adc.45.244.755.
11. Regala C, Cavaco D, Maciel J, et al. Endocrine manifestations in a paediatric cohort of 181 patients with neurofibromatosis type 1. Eur J Endocrinol 2025; 193: 216–222. doi: 10.1093/ejendo/lvaf147.
12. Pinheiro SL, Maciel J, Cavaco D, et al. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Hormones (Athens) 2023; 22: 79–85. doi: 10.1007/s42000-022-00411-9.
13. Carton C, Evans DG, Blanco I, et al. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalMedicine 2023; 56: 101818. doi: 10.1016/j.eclinm.2023.101818.
14. Elsayed W, Parker A. Annual review of children with neurofibromatosis type 1 (NF1). Approved by EPEN 2023.
15. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 1984; 91: 929–935. doi: 10.1016/s0161-6420(84)34217-8. 
16. Gutmann DH, Rasmussen SA, Wolkenstein P, et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 2002; 59: 759–761. doi: 10.1212/wnl.59.5.759.
17. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 2004; 63: 1944–1946. doi: 10.1212/01.wnl.0000144341.16830.01.
18. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997; 41: 143–149. doi: 10.1002/ana.410410204.


Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.